Apyx Medical Stock Forecast, Price & News

-0.15 (-1.53 %)
(As of 04/16/2021 04:00 PM ET)
Today's Range
Now: $9.64
50-Day Range
MA: $10.32
52-Week Range
Now: $9.64
Volume73,438 shs
Average Volume98,271 shs
Market Capitalization$330.83 million
P/E RatioN/A
Dividend YieldN/A
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Apyx Medical logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:APYX
Year FoundedN/A



Sales & Book Value

Annual Sales$28.15 million
Book Value$2.09 per share


Net Income$-19,710,000.00


Market Cap$330.83 million
Next Earnings Date5/12/2021 (Confirmed)


Comparing iCAD (NASDAQ:ICAD) and Apyx Medical (NASDAQ:APYX)
April 15, 2021 |
Apyx Medical: Q4 Earnings Insights
March 31, 2021 |
Apyx Medical's Earnings: A Preview
March 30, 2021 |
Illumina (ILMN) Sequencing & Microarray Sales Hurt by Pandemic
February 18, 2021 |
See More Headlines


Overall MarketRank

0.99 out of 5 stars

Medical Sector

1090th out of 2,024 stocks

Surgical & Medical Instruments Industry

99th out of 169 stocks

Analyst Opinion: 1.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
-0.15 (-1.53 %)
(As of 04/16/2021 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APYX News and Ratings via Email

Sign-up to receive the latest news and ratings for APYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Apyx Medical (NASDAQ:APYX) Frequently Asked Questions

Is Apyx Medical a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Apyx Medical stock.
View analyst ratings for Apyx Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Apyx Medical?

Wall Street analysts have given Apyx Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Apyx Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Apyx Medical's next earnings date?

Apyx Medical is scheduled to release its next quarterly earnings announcement on Wednesday, May 12th 2021.
View our earnings forecast for Apyx Medical

How can I listen to Apyx Medical's earnings call?

Apyx Medical will be holding an earnings conference call on Wednesday, May 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) announced its quarterly earnings data on Tuesday, March, 30th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.07. Apyx Medical had a negative net margin of 64.16% and a negative trailing twelve-month return on equity of 24.21%.
View Apyx Medical's earnings history

How has Apyx Medical's stock been impacted by COVID-19?

Apyx Medical's stock was trading at $5.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APYX stock has increased by 90.5% and is now trading at $9.64.
View which stocks have been most impacted by COVID-19

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical issued an update on its FY 2021 Pre-Market earnings guidance on Wednesday, March, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $36.7-38.7 million, compared to the consensus revenue estimate of $39.15 million.

What price target have analysts set for APYX?

3 Wall Street analysts have issued 1 year target prices for Apyx Medical's shares. Their forecasts range from $5.00 to $12.00. On average, they anticipate Apyx Medical's share price to reach $8.50 in the next twelve months. This suggests that the stock has a possible downside of 11.8%.
View analysts' price targets for Apyx Medical
or view top-rated stocks among Wall Street analysts.

Who are Apyx Medical's key executives?

Apyx Medical's management team includes the following people:
  • Mr. Charles D. Goodwin II, Pres, CEO & Director (Age 54, Pay $637.81k)
  • Ms. Tara H. Semb, CFO, Treasurer & Sec. (Age 51, Pay $411.06k)
  • Mr. Moshe Citronowicz, Sr. VP (Age 68, Pay $366.25k)
  • Mr. Todd Hornsby, Exec. VP (Age 45, Pay $462.47k)

Who are some of Apyx Medical's key competitors?

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), The Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), The Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

Who are Apyx Medical's major shareholders?

Apyx Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Calamos Advisors LLC (0.32%) and Wolff Wiese Magana LLC (0.11%).
View institutional ownership trends for Apyx Medical

Which major investors are selling Apyx Medical stock?

APYX stock was sold by a variety of institutional investors in the last quarter, including Wolff Wiese Magana LLC.
View insider buying and selling activity for Apyx Medical
or view top insider-selling stocks.

Which major investors are buying Apyx Medical stock?

APYX stock was purchased by a variety of institutional investors in the last quarter, including Calamos Advisors LLC.
View insider buying and selling activity for Apyx Medical
or or view top insider-buying stocks.

How do I buy shares of Apyx Medical?

Shares of APYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $9.64.

How much money does Apyx Medical make?

Apyx Medical has a market capitalization of $330.83 million and generates $28.15 million in revenue each year. The company earns $-19,710,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.

How many employees does Apyx Medical have?

Apyx Medical employs 266 workers across the globe.

What is Apyx Medical's official website?

The official website for Apyx Medical is

Where are Apyx Medical's headquarters?

Apyx Medical is headquartered at 5115 Ulmerton Road, Clearwater FL, 33760.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company can be reached via phone at 727-384-2323 or via email at [email protected]

This page was last updated on 4/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.